9:00am - 5:00pm

Office Hours Mon. - Fri.

800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

Estimated reading time: < 1 min

Condition

Malignant Pleural Effusion|Lung Cancer|Mesothelioma|Breast Cancer|Ovarian Cancer

Estimated Enrollment: 19

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: MpeTK01

Study First Received: November 19, 2013

Last Updated: December 30, 2016

Estimated Primary Completion Date: December 2015

Primary Outcome Measures:

Safety|Progression-free survival|Overall survival

Sponsors and Collaborators:

Advantagene, Inc.|University of Pennsylvania

Result Received: No Study Results Posted

Website Link: https://ClinicalTrials.gov/show/NCT01997190

Was this article helpful?
Views: 7